project id: TCGA-LUAD; case submitter id: TCGA-78-7160; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; a260 a280 ratio: 1.7; normal tumor genotype snp match: Yes; age at index: 61; days to birth: -22385; days to death: 697; ethnicity: not reported; gender: male; race: white; vital status: Dead; year of birth: 1947; age at diagnosis: 22385; ajcc pathologic m: M1; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 678.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; cigarettes per day: 2.4; pack years smoked: 43.8; years smoked: 35.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.8; longest dimension: 0.8; oct embedded: No; shortest dimension: 0.7; portion submitter id: TCGA-78-7160-01A-11; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 85.0; percent tumor nuclei: 60.0;